Literature DB >> 25387596

Newborn screening for SCID: where are we now?

Becky J Buelow1, John M Routes, James W Verbsky.   

Abstract

Newborn screening (NBS) for severe T-cell lymphopenia/severe combined immunodeficiency using the T-cell receptor excision circle assay continues to expand in the USA and worldwide. Here, we will review why severe combined immunodeficiency is an excellent case for NBS, the outcomes of the first 6 years of screening, and dilemmas surrounding screening and management of infants detected by NBS. We will also discuss the future of NBS for primary immunodeficiencies.

Entities:  

Keywords:  T-cell lymphopenia; TREC; newborn screening; severe combined immunodeficiency

Mesh：

Year:  2014        PMID： 25387596     DOI： 10.1586/1744666X.2014.980816

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


  1 in total

1.  Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.

Authors:  Michela Barbaro; Annika Ohlsson; Stephan Borte; Susanne Jonsson; Rolf H Zetterström; Jovanka King; Jacek Winiarski; Ulrika von Döbeln; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2016-11-21       Impact factor: 8.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.